Maarten van der Doelen

Appendices

Author

Affiliation

M.G. Looijen-Salamon Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands A.C.M. van de Luijtgaarden Department of Medical Oncology, Reinier de Graaf Gasthuis and Reinier Haga Prostate Cancer Center, Delft, The Netherlands Y. Ma Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden N. Mehra Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands A. Morgenstern Directorate for Nuclear Safety and Security, Joint Research Centre, Europe an Commission, Karlsruhe, Germany J. Nagarajah Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands S. Nilsson Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden I.M. van Oort Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands I. M. Oving Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, Netherlands W.J.G. Oyen Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arn hem, The Netherlands S. Pamidimarri Naga Department of Tumor Immunology, Radboud University Medical Center, Nijmegen, The Netherlands J.B. Prins Department of Medical Psychology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands W.D. van Schelven Department of Nuclear Medicine, Medical Centre Leeuwarden, Leeuwar den, The Netherlands J.P.M. Sedelaar Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands P.H.J. Slootbeek Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands D.M. Somford Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands A. Stockhaus Department of Oncology and Pathology, Mälarsjukhuset, Eskilstuna, Sweden F. Terheggen Department of Medical Oncology, Bravis Hospital, Roosendaal, The Neth erlands J. Textor Department of Tumor Immunology, Radboud University Medical Center, Nijmegen, The Netherlands A. Ullén Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden

246